Sequenom, Epoch Biosciences, Amersham, Aclara, Agilent, Gene Logic, NuGen Technologies, Epigenomics, Sanger Institute, Affymetrix, Abbott Laboratories, Vanderbilt | GenomeWeb

Sequenom Cuts 2003 Revenue Outlook by $4M

Sequenom has cut its 2003 revenue outlook by around $4 million, which would bring total revenues for the year below 2002 figures.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.